Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study-Reference-Cited by-同舟云学术

Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study

Published:2012-07-06 Issue:8 Volume:28 Page:1289-1296
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Aravind S.R.,Ismail Shaiful Bahari,Balamurugan R.,Gupta Jugal Bihari,Wadhwa Tarun,Loh Sze Min,Suryawanshi Shailaja,Davies Michael J.,Girman Cynthia J.,Katzeff Harvey L.,Radican Larry,Engel Samuel S.,Wolthers Troels

Publisher

Informa Healthcare

Subject

General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1185/03007995.2012.707119

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review;Diabetes Therapy;2024-06-27

2. Real-world evidence on the effectiveness and safety of gliclazide MR 60 mg in Bangladeshi patients with Type II diabetes during fasting: a sub-analysis from the global DIA-RAMADAN study;Journal of Comparative Effectiveness Research;2024-02

3. Expert consensus recommendations on the evaluation and management of hypoglycemia in diabetes: DGENius Group Diabetes India;Journal of Diabetology;2024-01

4. Diabetes and Ramadan fasting;BIDE' s Diabetes Desk Book;2024

5. Risk Stratification in People with Diabetes for Fasting During Ramadan: Consensus from Arabic Association for the Study of Diabetes and Metabolism;Current Diabetes Reviews;2023-10-20